NCT00047814 - Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

March 31, 2006

Conditions

Hepatitis C

Interventions

DRUG

FK788

Trial Locations (9)

Thomas Jefferson University, Gastroenterology and Hepatology, Philadelphia

Duke University, Durham

Carolinas Center for Liver Disease, Charlotte

University of Florida and Shands Hospital, Gainsville

Gastroenterology and Hepatology, Kansas City

Rocky Mount Gastroenterology, Lakewood

Liver Center Huntington Memorial Hospital, Pasadena

Northwest Medical Specialties, PLLC Infections Limited, P.S., Tacoma

Liver Center BIDMC - Harvard, Boston